GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VTGN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

VistaGen Therapeutics Inc stock upgraded from Sell Candidate to Hold/Accumulate after Thursday trading session.
(Updated on Apr 18, 2024)

Hold candidate since Apr 18, 2024 PDF

The VistaGen Therapeutics Inc stock price gained 0.642% on the last trading day (Thursday, 18th Apr 2024), rising from $4.67 to $4.70. During the last trading day the stock fluctuated 4.78% from a day low at $4.60 to a day high of $4.82. The price has been going up and down for this period, and there has been a -11.15% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 79 thousand more shares were traded than the day before. In total, 193 thousand shares were bought and sold for approximately $908.82 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.24% during the next 3 months and, with a 90% probability hold a price between $3.79 and $5.26 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VTGN Signals & Forecast

The VistaGen Therapeutics Inc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $4.87. On a fall, the stock will find some support from the long-term average at approximately $4.66. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 1.08%. Further rise is indicated until a new top pivot has been found. VistaGen Therapeutics Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for VistaGen Therapeutics Inc stock

VistaGen Therapeutics Inc finds support from accumulated volume at $4.49 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.220 between high and low, or 4.78%. For the last week, the stock has had daily average volatility of 7.00%.

Our recommended stop-loss: $4.42 (-5.91%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (VTGN) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect VistaGen Therapeutics Inc to open at $4.71, and during the day (based on 14 day Average True Range), to move between $4.37 and $5.03, which gives a possible trading interval of +/-$0.326 (+/-6.93%) up or down from last closing price. If VistaGen Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 13.86% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.85 (3.19%) than the support at $4.49 (4.47%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is VistaGen Therapeutics Inc stock A Buy?

VistaGen Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.529 Hold/Accumulate Upgraded

Predicted Opening Price for VistaGen Therapeutics Inc of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$4.71 ( 0.142%) $4.70

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VTGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.93 4.82 %
R2 4.84 3.03 %
R1 4.79 1.93 %
Current price: 4.70
Support S1 4.62 -1.65 %
S2 4.57 -2.75 %
S3 4.49 -4.54 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.40 14.89 %
R2 5.28 12.34 %
R1 4.85 3.19 %
Current price 4.70
Support S1 4.49 -4.47%
S2 4.24 -9.89%
S3 4.17 -11.28%

FAQ

What is the symbol for VistaGen Therapeutics Inc Stock and on which exchange is it traded?
The symbol for VistaGen Therapeutics Inc is VTGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell VistaGen Therapeutics Inc Stock?
VistaGen Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy VistaGen Therapeutics Inc Stock?
VistaGen Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy VistaGen Therapeutics Inc Stock.

What's the current price of VistaGen Therapeutics Inc Stock?
As of the end of day on the 2024-04-18, the price of an VistaGen Therapeutics Inc (VTGN) share was $4.70.

What is the 52-week high and low for VistaGen Therapeutics Inc Stock?
The 52-week high for VistaGen Therapeutics Inc Stock is $24.71 and the 52-week low is $1.62.

What is the market capitalization of VistaGen Therapeutics Inc Stock?
As of the 2024-04-18, the market capitalization of VistaGen Therapeutics Inc is 126.208M.

When is the next earnings date for VistaGen Therapeutics Inc?
The upcoming earnings date for VistaGen Therapeutics Inc is Jun 26, 2024.
Click to get the best stock tips daily for free!

About VistaGen Therapeutics Inc

VistaGen Therapeutics VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product... VTGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT